For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...

Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...

The United States can no longer keep tabs on drug-resistant gonorrhea, among other infections, scientists said.

The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...

Higher treatment rates were seen for females, individuals aged 10 to 29 years, suburban dwellers, and patients with chlamydia-gonorrhea coinfection. HealthDay News — Across primary care ...

Researchers from the universities in Konstanz and Vienna have discovered a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhea. These substances ...

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...

Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce ...

This study aimed to quantify the overall treatment rate for chlamydia and gonorrhea and identify factors associated with treatment delays and disparities.